| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,248 |
16,661 |
$3.23M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,935 |
10,956 |
$2.19M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,272 |
5,312 |
$1.98M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
13,402 |
4,197 |
$642K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,462 |
3,152 |
$484K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,251 |
2,011 |
$426K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,823 |
2,296 |
$366K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,970 |
1,741 |
$362K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
662 |
631 |
$249K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,931 |
1,593 |
$234K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,241 |
1,590 |
$179K |
| 97162 |
|
1,116 |
1,036 |
$156K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
824 |
762 |
$146K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,686 |
1,523 |
$146K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,232 |
2,671 |
$141K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
871 |
813 |
$140K |
| G0378 |
Hospital observation service, per hour |
597 |
499 |
$80K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
374 |
341 |
$77K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,778 |
1,675 |
$74K |
| 97161 |
|
395 |
378 |
$63K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,657 |
1,296 |
$61K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,058 |
2,722 |
$61K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,391 |
751 |
$46K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
107 |
100 |
$42K |
| 80053 |
Comprehensive metabolic panel |
11,841 |
9,610 |
$38K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
99 |
91 |
$32K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
140 |
127 |
$24K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
88 |
76 |
$23K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
214 |
128 |
$23K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
101 |
95 |
$21K |
| 71046 |
Radiologic examination, chest; 2 views |
3,734 |
3,332 |
$17K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
83 |
78 |
$17K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
27 |
26 |
$16K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,189 |
6,772 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,291 |
2,757 |
$13K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
236 |
222 |
$11K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
25 |
24 |
$9K |
| 72141 |
|
34 |
33 |
$8K |
| 80047 |
|
2,442 |
2,098 |
$8K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
27 |
25 |
$8K |
| 76942 |
|
352 |
283 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,164 |
12,467 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
4,840 |
4,174 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,373 |
2,580 |
$6K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
54 |
52 |
$5K |
| 84484 |
|
5,584 |
3,660 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,037 |
5,745 |
$4K |
| 64450 |
|
30 |
24 |
$4K |
| 20610 |
|
21 |
17 |
$4K |
| 73630 |
|
289 |
263 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
5,875 |
4,814 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,230 |
1,982 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,292 |
4,853 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
780 |
706 |
$3K |
| J3490 |
Unclassified drugs |
7,687 |
4,023 |
$3K |
| 97750 |
|
128 |
116 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
214 |
198 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,897 |
2,737 |
$3K |
| 83880 |
|
476 |
397 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
95 |
54 |
$3K |
| 97163 |
|
14 |
12 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
723 |
644 |
$2K |
| 87510 |
|
400 |
373 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
7,025 |
3,459 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,211 |
3,473 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
898 |
596 |
$2K |
| 85379 |
|
638 |
605 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,229 |
4,019 |
$2K |
| 73610 |
|
177 |
151 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
489 |
385 |
$1K |
| 73030 |
|
127 |
122 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
26 |
25 |
$1K |
| 73562 |
|
73 |
58 |
$1K |
| 83605 |
|
2,328 |
1,569 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,235 |
3,591 |
$1K |
| 87040 |
|
218 |
191 |
$1K |
| 87660 |
|
400 |
373 |
$1K |
| 85652 |
|
329 |
311 |
$967.86 |
| 90715 |
|
42 |
41 |
$925.67 |
| 93971 |
|
16 |
14 |
$886.33 |
| 81001 |
|
8,643 |
7,298 |
$867.03 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,451 |
1,235 |
$851.58 |
| 94726 |
|
32 |
25 |
$767.34 |
| 81025 |
|
5,257 |
4,607 |
$760.82 |
| 82947 |
|
4,167 |
2,345 |
$633.07 |
| 80076 |
|
212 |
187 |
$611.21 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,167 |
3,382 |
$551.10 |
| 86885 |
|
214 |
189 |
$542.13 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,673 |
1,052 |
$538.59 |
| 73130 |
|
82 |
63 |
$530.38 |
| 97116 |
|
23 |
12 |
$492.17 |
| 86900 |
|
392 |
356 |
$474.11 |
| 83735 |
|
2,654 |
1,968 |
$452.17 |
| A9150 |
Non-prescription drugs |
24,343 |
9,913 |
$416.53 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,412 |
2,967 |
$367.90 |
| 94729 |
|
32 |
25 |
$329.73 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
754 |
682 |
$314.26 |
| 86901 |
|
392 |
356 |
$306.36 |
| 86140 |
|
191 |
155 |
$298.29 |
| 73502 |
|
27 |
24 |
$289.13 |
| 97802 |
|
12 |
12 |
$272.88 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,088 |
978 |
$271.92 |
| 85610 |
|
766 |
670 |
$270.94 |
| 82077 |
|
1,823 |
1,534 |
$270.00 |
| 85014 |
|
2,614 |
2,231 |
$264.27 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
219 |
184 |
$260.01 |
| 83690 |
|
4,090 |
3,402 |
$257.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,745 |
2,166 |
$207.01 |
| 87077 |
|
1,052 |
834 |
$185.11 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,268 |
1,965 |
$177.19 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,883 |
1,407 |
$152.01 |
| 81003 |
|
688 |
562 |
$150.33 |
| 86756 |
|
199 |
183 |
$148.48 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
57 |
54 |
$146.28 |
| 87081 |
|
991 |
937 |
$144.69 |
| 73560 |
|
124 |
117 |
$124.20 |
| 73110 |
|
13 |
12 |
$122.06 |
| 74018 |
|
12 |
12 |
$118.54 |
| 87186 |
|
740 |
581 |
$112.31 |
| 84703 |
|
1,168 |
1,083 |
$109.17 |
| 87430 |
|
1,190 |
1,122 |
$73.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
959 |
705 |
$71.60 |
| 36592 |
|
175 |
138 |
$64.42 |
| 80061 |
Lipid panel |
16 |
13 |
$60.28 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
790 |
596 |
$55.44 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
579 |
280 |
$47.14 |
| 87480 |
|
400 |
373 |
$46.71 |
| 81002 |
|
1,231 |
1,075 |
$33.49 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
299 |
223 |
$29.67 |
| 00813 |
|
98 |
88 |
$24.86 |
| 96376 |
|
1,151 |
787 |
$18.46 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,983 |
1,595 |
$15.16 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
107 |
100 |
$12.20 |
| 84100 |
|
68 |
51 |
$10.88 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
73 |
38 |
$8.55 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
558 |
439 |
$8.41 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
144 |
112 |
$6.25 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
462 |
361 |
$3.35 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
42 |
37 |
$2.99 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
17 |
12 |
$2.64 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
70 |
63 |
$1.44 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
39 |
28 |
$0.92 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
57 |
52 |
$0.72 |
| 85730 |
|
14 |
12 |
$0.40 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
54 |
51 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
190 |
119 |
$0.00 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
199 |
171 |
$0.00 |
| 80179 |
|
16 |
13 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
206 |
178 |
$0.00 |
| 80143 |
|
16 |
13 |
$0.00 |
| 84702 |
|
14 |
12 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
14 |
14 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
89 |
83 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
25 |
19 |
$0.00 |
| 84295 |
|
22 |
15 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
772 |
689 |
$0.00 |
| A9270 |
Non-covered item or service |
1,242 |
414 |
$0.00 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
107 |
94 |
$0.00 |
| A6454 |
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard |
12 |
12 |
$0.00 |
| 88342 |
|
20 |
14 |
$0.00 |
| 82330 |
|
22 |
15 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
144 |
118 |
$0.00 |
| 82803 |
|
14 |
12 |
$0.00 |
| 84132 |
|
22 |
15 |
$0.00 |